347 related articles for article (PubMed ID: 27339384)
1. Out of the TWEAKlight: Elucidating the Role of Fn14 and TWEAK in Acute Kidney Injury.
Sanz AB; Ruiz-Andres O; Sanchez-Niño MD; Ruiz-Ortega M; Ramos AM; Ortiz A
Semin Nephrol; 2016 May; 36(3):189-98. PubMed ID: 27339384
[TBL] [Abstract][Full Text] [Related]
2. Bcl3: a regulator of NF-κB inducible by TWEAK in acute kidney injury with anti-inflammatory and antiapoptotic properties in tubular cells.
Poveda J; Sanz AB; Carrasco S; Ruiz-Ortega M; Cannata-Ortiz P; Sanchez-Niño MD; Ortiz A
Exp Mol Med; 2017 Jul; 49(7):e352. PubMed ID: 28684863
[TBL] [Abstract][Full Text] [Related]
3. Tweak/Fn14 system is involved in rhabdomyolysis-induced acute kidney injury.
Guerrero-Hue M; Vallejo-Mudarra M; García-Caballero C; Córdoba-David GM; Palomino-Antolín A; Herencia C; Vendrell-Casana B; Rubio-Navarro A; Egido J; Blanco-Colio LM; Moreno JA
Biomed Pharmacother; 2023 Dec; 169():115925. PubMed ID: 38007933
[TBL] [Abstract][Full Text] [Related]
4. TWEAK and RIPK1 mediate a second wave of cell death during AKI.
Martin-Sanchez D; Fontecha-Barriuso M; Carrasco S; Sanchez-Niño MD; Mässenhausen AV; Linkermann A; Cannata-Ortiz P; Ruiz-Ortega M; Egido J; Ortiz A; Sanz AB
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):4182-4187. PubMed ID: 29588419
[TBL] [Abstract][Full Text] [Related]
5. TWEAK/Fn14 promotes oxidative stress through AMPK/PGC‑1α/MnSOD signaling pathway in endothelial cells.
Liu H; Peng H; Xiang H; Guo L; Chen R; Zhao S; Chen W; Chen P; Lu H; Chen S
Mol Med Rep; 2018 Jan; 17(1):1998-2004. PubMed ID: 29257217
[TBL] [Abstract][Full Text] [Related]
6. Targeting the TWEAK-Fn14 pathway prevents dysfunction in cardiac calcium handling after acute kidney injury.
Poveda J; González-Lafuente L; Vázquez-Sánchez S; Mercado-García E; Rodríguez-Sánchez E; García-Consuegra I; Sanz AB; Segura J; Fernández-Velasco M; Liaño F; Ruilope LM; Ruiz-Hurtado G
J Pathol; 2023 Dec; 261(4):427-441. PubMed ID: 37776271
[TBL] [Abstract][Full Text] [Related]
7. Acute kidney injury transcriptomics unveils a relationship between inflammation and ageing.
Izquierdo MC; Sanz AB; Sánchez-Niño MD; Pérez-Gómez MV; Ruiz-Ortega M; Poveda J; Ruiz-Andrés O; Ramos AM; Moreno JA; Egido J; Ortiz A
Nefrologia; 2012; 32(6):715-23. PubMed ID: 23093094
[TBL] [Abstract][Full Text] [Related]
8. The inflammatory cytokine TWEAK decreases PGC-1α expression and mitochondrial function in acute kidney injury.
Ruiz-Andres O; Suarez-Alvarez B; Sánchez-Ramos C; Monsalve M; Sanchez-Niño MD; Ruiz-Ortega M; Egido J; Ortiz A; Sanz AB
Kidney Int; 2016 Feb; 89(2):399-410. PubMed ID: 26535995
[TBL] [Abstract][Full Text] [Related]
9. TWEAK/Fn14 Activation Participates in Skin Inflammation.
Liu Q; Xiao S; Xia Y
Mediators Inflamm; 2017; 2017():6746870. PubMed ID: 29038621
[TBL] [Abstract][Full Text] [Related]
10. TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-κB pathway.
Zhu C; Zhang L; Liu Z; Li C; Bai Y
J Cell Biochem; 2018 Apr; 119(4):3528-3536. PubMed ID: 29143982
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of suppressor of cytokine signaling 1 mediates the profibrotic effect of TWEAK/Fn14 signaling on kidney cells.
Chen J; Jia F; Ren K; Luo M; Min X; Wang P; Xiao S; Xia Y
Cell Signal; 2020 Jul; 71():109615. PubMed ID: 32217132
[TBL] [Abstract][Full Text] [Related]
12. Interruption of neutrophil extracellular traps formation dictates host defense and tubular HOXA5 stability to augment efficacy of anti-Fn14 therapy against septic AKI.
Ni Y; Hu BC; Wu GH; Shao ZQ; Zheng Y; Zhang R; Jin J; Hong J; Yang XH; Sun RH; Liu JQ; Mo SJ
Theranostics; 2021; 11(19):9431-9451. PubMed ID: 34646379
[TBL] [Abstract][Full Text] [Related]
13. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
[TBL] [Abstract][Full Text] [Related]
14. TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease.
Gomez IG; Roach AM; Nakagawa N; Amatucci A; Johnson BG; Dunn K; Kelly MC; Karaca G; Zheng TS; Szak S; Peppiatt-Wildman CM; Burkly LC; Duffield JS
J Am Soc Nephrol; 2016 Dec; 27(12):3639-3652. PubMed ID: 27026366
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-inducible 14 mediates macrophage infiltration in heart to promote pressure overload-induced cardiac dysfunction.
Unudurthi SD; Nassal DM; Patel NJ; Thomas E; Yu J; Pierson CG; Bansal SS; Mohler PJ; Hund TJ
Life Sci; 2020 Apr; 247():117440. PubMed ID: 32070706
[TBL] [Abstract][Full Text] [Related]
16. TWEAK and the progression of renal disease: clinical translation.
Sanz AB; Izquierdo MC; Sanchez-Niño MD; Ucero AC; Egido J; Ruiz-Ortega M; Ramos AM; Putterman C; Ortiz A
Nephrol Dial Transplant; 2014 Feb; 29 Suppl 1(Suppl 1):i54-i62. PubMed ID: 24493870
[TBL] [Abstract][Full Text] [Related]
17. TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.
Izquierdo MC; Sanz AB; Mezzano S; Blanco J; Carrasco S; Sanchez-Niño MD; Benito-Martín A; Ruiz-Ortega M; Egido J; Ortiz A
Kidney Int; 2012 Jun; 81(11):1098-107. PubMed ID: 22278019
[TBL] [Abstract][Full Text] [Related]
18. TWEAK, a multifunctional cytokine in kidney injury.
Sanz AB; Sanchez-Niño MD; Ortiz A
Kidney Int; 2011 Oct; 80(7):708-18. PubMed ID: 21697814
[TBL] [Abstract][Full Text] [Related]
19. Cytokine cooperation in renal tubular cell injury: the role of TWEAK.
Justo P; Sanz AB; Sanchez-Niño MD; Winkles JA; Lorz C; Egido J; Ortiz A
Kidney Int; 2006 Nov; 70(10):1750-8. PubMed ID: 17003819
[TBL] [Abstract][Full Text] [Related]
20. The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock.
Mendez-Barbero N; Yuste-Montalvo A; Nuñez-Borque E; Jensen BM; Gutiérrez-Muñoz C; Tome-Amat J; Garrido-Arandia M; Díaz-Perales A; Ballesteros-Martinez C; Laguna JJ; Beitia JM; Poulsen LK; Cuesta-Herranz J; Blanco-Colio LM; Esteban V
J Allergy Clin Immunol; 2020 Feb; 145(2):583-596.e6. PubMed ID: 31679818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
